Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Epidemiology & Intervention Research for Tobacco Control
This study has been completed.
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00076921
  Purpose

To train tobacco control researchers who can work individually and collaboratively to carry out tobacco control research and use the evidence to implement effective interventions that will result in policy and behavioral change.


Condition Phase
Lung Diseases
N/A

U.S. FDA Resources
Study Type: Observational

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 2002
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Detailed Description:

BACKGROUND:

The low and middle-income countries of the world face a rising threat to public health from the rapidly escalating epidemic of tobacco use. Strong evidence based programs are urgently needed to promote tobacco control. However, few less developed countries have sufficient infrastructure or capacity for tobacco control research, and funding for such research may be unavailable or extremely limited. This study builds on the strong partnerships already established by the Institute for Global Tobacco Control of the Bloomberg School of Public Health and sets out a strategy for enhanced tobacco control research and capacity building in Asia and Latin America.

The study is in response to a Request for Applications titled "International Tobacco and Health Research and Capacity Building Program" released jointly in June, 2001 by the Fogarty International Center, the National Cancer Institute, the National Institute of Child Health and Human Development, the National Institute of Mental Health, the National Institute of Nursing Research, and the National Institute of Drug Abuse.

DESIGN NARRATIVE:

The core elements of the program will include in-depth training of tobacco control leaders in the regions, regional training and policy relevant epidemiologic and intervention research. Established researchers will receive in-depth training at the Johns Hopkins Bloomberg School of Public Health to equip them not only with needed research competencies but also with an understanding of the relationship between tobacco control evidence and effective policy. Regional training workshops will focus on key regional needs and help to establish a network of tobacco control experts within and between countries who can develop and implement collaborative research projects. Research needs will be established through interactions with stakeholder groups and policy makers in each region. For the initial year, research projects are proposed based on research needs identified as policy relevant through prior collaborations. In Brazil, a national survey in 9,000 residents of tobacco use and tobacco related knowledge, attitudes and behavior is proposed in collaboration with the National Cancer Institute. In China, the proposed research effort is a community intervention trial in 800 families, focusing on the creation of smoke free homes with the Chinese Academy of Preventive Medicine. In Mexico, the Institute plans to work with its partner, the National Institute for Public Health, to estimate smoking attributable morbidity and mortality, and associated costs in 1,200 cases and controls.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

No eligibility criteria

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00076921

Sponsors and Collaborators
Investigators
Investigator: Jonathan Samet Johns Hopkins University
  More Information

Publications:
Study ID Numbers: 1209
Study First Received: February 6, 2004
Last Updated: July 23, 2008
ClinicalTrials.gov Identifier: NCT00076921  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Respiratory Tract Diseases
Lung Diseases

ClinicalTrials.gov processed this record on January 15, 2009